Literature DB >> 3019703

Effect of acarbose on carbohydrate tolerance during administration of a fibre-free formula diet on healthy subjects.

I E Walter-Sack, A Ittner-Holland, G Wolfram, N Zoellner.   

Abstract

The influence of the disaccharidase inhibitor acarbose on carbohydrate tolerance was investigated in healthy subjects during substitution of fibre-free formula diets for normal food. Two separate experiments showed that acarbose was highly efficient in retarding and diminishing the postprandial rise in blood glucose and serum insulin when administered with these diets for 10 to 14 days. Acarbose decreased the area under the postprandial curves of blood glucose from 1.836 to -504 mg/dl X min in Study 1, and from 587 to -302 mg/dl X min in Study 2. The area under the serum insulin curves was reduced from 5.022 to 1.440 microU/ml X min in Study 1, and from 7.990 to 918 microU/ml X min in Study 2. In addition, acarbose greatly diminished the interindividual variation in postprandial serum insulin concentration. Its efficacy in reducing the glycaemic response to a test meal in both experiments was found to depend on the time of initiation of therapy; in contrast, the serum insulin response was only time-dependent in Study 2. Use of fibre-free diets to standardise experimental conditions proved to be a valuable tool in investigating these details.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019703     DOI: 10.1007/bf00542422

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Combined use of guar and acarbose in reduction of postprandial glycaemia.

Authors:  D J Jenkins; R H Taylor; R Nineham; D V Goff; S R Bloom; D Sarson; K G Alberti
Journal:  Lancet       Date:  1979-11-03       Impact factor: 79.321

2.  Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.

Authors:  G Sachse; B Willms
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

3.  Inhibition of human intestinal alpha-glucosidehydrolases by a new complex oligosaccharide.

Authors:  W F Caspary; S Graf
Journal:  Res Exp Med (Berl)       Date:  1979-04-23

Review 4.  The use of liquid formula diets in metabolic studies: 15 years' experience.

Authors:  E H Ahrens
Journal:  Adv Metab Disord       Date:  1970

5.  Optimum effectiveness of intestinal alpha-glucosidase inhibitors: importance of uniform distribution through a meal.

Authors:  K O'Dea; J Turton
Journal:  Am J Clin Nutr       Date:  1985-03       Impact factor: 7.045

6.  Delay of carbohydrate absorption by inhibitors of intestinal alpha-glucosidases.

Authors:  W Puls; H P Krause
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

7.  The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.

Authors:  I Hillebrand; K Boehme; G Frank; H Fink; P Berchtold
Journal:  Res Exp Med (Berl)       Date:  1979-04-23

8.  [Effect of glucosidase inhibitor, Bay g 5421 (acarbose), on the blood glucose in obese diabetic patients ty pe 2 (NIDDM) (author's transl)].

Authors:  H Laube; M Fouladfar; R Aubell; H Schmitz
Journal:  Arzneimittelforschung       Date:  1980

9.  Acarbose treatment of non-insulin-dependent diabetes mellitus.

Authors:  C K Lardinois; M S Greenfield; H C Schwartz; H J Vreman; G M Reaven
Journal:  Arch Intern Med       Date:  1984-02

10.  Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.

Authors:  R J Walton; I T Sherif; G A Noy; K G Alberti
Journal:  Br Med J       Date:  1979-01-27
View more
  2 in total

1.  Alteration of oral carbohydrate tolerance during administration of a fiber-free formula diet.

Authors:  I Walter-Sack; G Wolfram; N Zöllner
Journal:  Klin Wochenschr       Date:  1987-02-02

2.  Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro.

Authors:  M Hiele; Y Ghoos; P Rutgeerts; G Vantrappen
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.